Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Eton Pharmaceuticals (ETON) Leases (2019 - 2025)

Eton Pharmaceuticals' Leases history spans 7 years, with the latest figure at $319000.0 for Q3 2025.

  • For Q3 2025, Leases rose 209.71% year-over-year to $319000.0; the TTM value through Sep 2025 reached $319000.0, up 209.71%, while the annual FY2024 figure was $175000.0, 90.22% up from the prior year.
  • Leases for Q3 2025 was $319000.0 at Eton Pharmaceuticals, down from $324000.0 in the prior quarter.
  • Across five years, Leases topped out at $324000.0 in Q2 2025 and bottomed at $42000.0 in Q3 2022.
  • The 5-year median for Leases is $103000.0 (2024), against an average of $131684.2.
  • The largest annual shift saw Leases plummeted 56.21% in 2024 before it soared 209.71% in 2025.
  • A 5-year view of Leases shows it stood at $104000.0 in 2021, then tumbled by 31.73% to $71000.0 in 2022, then rose by 29.58% to $92000.0 in 2023, then surged by 90.22% to $175000.0 in 2024, then skyrocketed by 82.29% to $319000.0 in 2025.
  • Per Business Quant, the three most recent readings for ETON's Leases are $319000.0 (Q3 2025), $324000.0 (Q2 2025), and $158000.0 (Q1 2025).